H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair
To integrate complementary pharmacological properties relevant to cutaneous wound repair, we designed and synthesized six novel molecular hybrids combining a JAK1-targeting 7H-pyrrolo[2,3-d]pyrimidine scaffold with selected hydrogen sulfide (H2S)-releasing moieties. The compounds were characterized for their H2S-releasing properties and evaluated in human HaCaT keratinocytes, using abrocitinib, a selective JAK1 inhibitor, as a reference compound. Compounds II, III, and V emerged as the most promising derivatives, displaying marked pro-migratory activity in both scratch wound and Transwell assays, with effects exceeding those of the corresponding H2S donors and abrocitinib under the tested conditions. Notably, compounds II, III, and V exhibited distinct cysteine-dependent H2S-release profiles, characterized by a progressive increase followed by a relatively stable plateau during the 30-min amperometric assay performed at 100 µM. Molecular docking studies supported the ability of the selected hybrids to retain key interactions within the JAK1 binding pocket, while highlighting linker-dependent differences in ligand orientation. Further biological characterization showed that compounds II and V modulated the expression of the extracellular matrix-related genes COL1A1, MMP2, and MMP9, whereas compounds II, III, and V attenuated IFN-γ/TNF-α-induced STAT1 phosphorylation with effects comparable to abrocitinib. Under inflammatory conditions, compounds II and V also counteracted the cytokine-induced reduction in COL1A1 expression. Overall, these findings identify compounds II, III, and V as promising multifunctional H2S-releasing molecular hybrids and support the development of H2S-based hybrid pharmacological strategies combining H2S-releasing properties with enhanced keratinocyte migration, modulation of extracellular matrix-related responses, and attenuation of cytokine-induced STAT1 activation.
Authors
- Vincenzo Santagada (ORCID: https://orcid.org/0000-0001-8377-8990)
- Vincenzo Calderone (ORCID: https://orcid.org/0000-0002-1441-5421)
- Ferdinando Fiorino (ORCID: https://orcid.org/0000-0001-7357-5751)
- Beatrice Ulloa Severino (ORCID: https://orcid.org/0000-0002-3887-8869)
- Francesco Frecentese (ORCID: https://orcid.org/0000-0001-8821-2937)
- Angela Ianaro (ORCID: https://orcid.org/0000-0003-2520-9647)
- Elisa Perissutti (ORCID: https://orcid.org/0000-0002-1754-1191)
- Valentina Citi (ORCID: https://orcid.org/0000-0001-9261-8497)
- Elisa Magli (ORCID: https://orcid.org/0000-0002-9930-9467)
- Rosa Sparaco (ORCID: https://orcid.org/0009-0003-4221-5560)
- Giuseppe Caliendo (ORCID: https://orcid.org/0000-0002-5098-6045)
- Giuseppe Ercolano (ORCID: https://orcid.org/0000-0001-6026-2588)
- Roberta Palladino (ORCID: https://orcid.org/0009-0002-7508-5152)
- Alma Martelli (ORCID: https://orcid.org/0000-0002-2090-7107)
- Barbara Maglione (ORCID: https://orcid.org/0000-0001-8516-2647)
- Benedetta Romano
- Eugenia Romano (ORCID: https://orcid.org/0000-0002-1500-6478)
- Pierfrancesco Cinque
- Fabio Somma
- Giorgia Andreozzi
- Lidia Ciriaco (ORCID: https://orcid.org/0000-0002-2609-6851)
- Stefania Vertuccio (ORCID: https://orcid.org/0009-0004-0542-132X)
- Letizia Dani
Institutions
- University of Pisa (IT)
- Farmaceutici Damor (Italy) (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Antioxidants
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/antiox15111504
- Primary Topic
- Wound Healing and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00